SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $159,000 | +65.6% | 10,200 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $96,000 | +5.5% | 10,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $91,000 | +40.0% | 10,200 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $65,000 | -55.8% | 10,200 | -67.9% | 0.00% | -40.0% |
| Q3 2016 | $147,000 | -20.1% | 31,750 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $184,000 | -4.2% | 31,750 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $192,000 | +111.0% | 31,750 | +217.5% | 0.01% | +133.3% |
| Q4 2015 | $91,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |